|
|
 |
|
Viewing report
|
|
|
|
Allergan Inc.: PharmaVitae Model
Datamonitor, March 2009, Pages: 86
This analysis examines the historical and forecast performance for Allergan in the Rx pharmaceutical sector. The profile encompasses global company strategy, portfolio and pipeline analysis and assessment of financial performance, with 1-6 year sales forecasts for key drugs. An interactive forecasting and analysis tool provides continually updated quantitative and qualitative information
Reasons to Purchase
- Benchmark Allergan's performance against key rivals in the prescription pharmaceutical sector
- Assess how the Botox franchise, which straddles both the cosmetic and pharmaceutical segments, will continue to shape Allergan's commercial performance
- Analyse the impact of Allergan's acquisition of Esprit Pharma in 2007, namely its movement into the urology therapy market
Customers who bought this item also bought
Allergan Inc.: PharmaVitae Profile
Allergan: Performance, Products, Pipeline and Potential
Allergan, Inc. Product Pipeline Analysis
Company Analysis - Allergan, Inc.
Allergan: PharmaVitae Profile
Allergan, Inc. - SWOT Analysis
Allergan IMS Company Profiles
Pharmavitae 2005: Allergan Global Analysis
PharmaVitae 2004: Allergan Global Analysis
Pharmavitae 2005: Allergan Global & Us Analysis
PharmaVitae 2004: Allergan Global & US Analysis
Allergan, Inc.
|
|
|
|
